![](/img/cover-not-exists.png)
Adding paclitaxel to supportive care seems to improve survival and delay time to progression in people with non-small cell lung cancer
Raymond AbrattVolume:
1
Year:
2000
Language:
english
Pages:
2
DOI:
10.1054/ebon.2000.0066
File:
PDF, 141 KB
english, 2000